Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Miles Miller, Ph.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. DP2CA259675 (MILLER, MILES A) Sep 4, 2020 - May 31, 2025
    Dissection of in situ myeloid signaling using image-guided synthetic control
    Role: Principal Investigator
  2. R00CA207744 (MILLER, MILES A) Jul 1, 2018 - Jun 30, 2021
    Single Cell In Vivo Imaging Technology to Analyze Taxane Nano Formulations in Breast Cancer
    Role: Principal Investigator
  3. K99CA207744 (MILLER, MILES A) Jul 1, 2016 - Jun 30, 2018
    Single Cell In Vivo Imaging Technology to Analyze Taxane Nano Formulations in Breast Cancer
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Villalba JA, Hilburn CF, Garlin MA, Elliott GA, Li Y, Kunitoki K, Poli S, Alba GA, Madrigal E, Taso M, Price MC, Aviles AJ, Araujo-Medina M, Bonanno L, Boyraz B, Champion SN, Harris CK, Helland TL, Hutchison B, Jobbagy S, Marshall MS, Shepherd DJ, Barth JL, Hung YP, Ly A, Hariri LP, Turbett SE, Pierce VM, Branda JA, Rosenberg ES, Mendez-Pena J, Chebib I, Rosales IA, Smith RN, Miller MA, Rosas IO, Hardin CC, Baden LR, Medoff BD, Colvin RB, Little BP, Stone JR, Mino-Kenudson M, Shih AR. Vasculopathy and Increased Vascular Congestion in Fatal COVID-19 and Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2022 Oct 01; 206(7):857-873. PMID: 35671465.
    Citations: 4     Fields:    
  2. Quintana JM, Arboleda D, Hu H, Scott E, Luthria G, Pai S, Parangi S, Weissleder R, Miller MA. Radiation Cleaved Drug-Conjugate Linkers Enable Local Payload Release. Bioconjug Chem. 2022 08 17; 33(8):1474-1484. PMID: 35833631; PMCID: PMC9390333.
    Citations:    Fields:    
  3. Ng TSC, Hu H, Kronister S, Lee C, Li R, Gerosa L, Stopka SA, Burgenske DM, Khurana I, Regan MS, Vallabhaneni S, Putta N, Scott E, Matvey D, Giobbie-Hurder A, Kohler RH, Sarkaria JN, Parangi S, Sorger PK, Agar NYR, Jacene HA, Sullivan RJ, Buchbinder E, Mikula H, Weissleder R, Miller MA. Overcoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy. Sci Adv. 2022 Apr 29; 8(17):eabl6339. PMID: 35486732; PMCID: PMC9054019.
    Citations: 2     Fields:    
  4. Ng TSC, Allen HH, Rashidian M, Miller MA. Probing immune infiltration dynamics in cancer by in vivo imaging. Curr Opin Chem Biol. 2022 04; 67:102117. PMID: 35219177; PMCID: PMC9118268.
    Citations: 2     Fields:    Translation:HumansCells
  5. Cook L, Sengelmann M, Winkler B, Nagl C, Koch S, Schlomann U, Slater EP, Miller MA, von Strandmann EP, Dörsam B, Preußer C, Bartsch JW. ADAM8-Dependent Extracellular Signaling in the Tumor Microenvironment Involves Regulated Release of Lipocalin 2 and MMP-9. Int J Mol Sci. 2022 Feb 10; 23(4). PMID: 35216088; PMCID: PMC8875419.
    Citations: 3     Fields:    Translation:HumansCells
  6. Matvey DO, Ng TSC, Miller MA. Confocal Imaging of Single-Cell Signaling in Orthotopic Models of Ovarian Cancer. Methods Mol Biol. 2022; 2424:295-315. PMID: 34918302.
    Citations:    Fields:    Translation:AnimalsCells
  7. Luthria G, Lauffenburger D, Miller MA. Cell-Cell Communication Networks in Tissue: Toward Quantitatively Linking Structure with Function. Curr Opin Syst Biol. 2021 Sep; 27. PMID: 34693081; PMCID: PMC8530179.
  8. Li R, Ng TSC, Wang SJ, Prytyskach M, Rodell CB, Mikula H, Kohler RH, Garlin MA, Lauffenburger DA, Parangi S, Dinulescu DM, Bardeesy N, Weissleder R, Miller MA. Therapeutically reprogrammed nutrient signalling enhances nanoparticulate albumin bound drug uptake and efficacy in KRAS-mutant cancer. Nat Nanotechnol. 2021 07; 16(7):830-839. PMID: 33958764; PMCID: PMC8491539.
    Citations: 16     Fields:    Translation:HumansAnimalsCells
  9. Stewart-Ornstein J, Iwamoto Y, Miller MA, Prytyskach MA, Ferretti S, Holzer P, Kallen J, Furet P, Jambhekar A, Forrester WC, Weissleder R, Lahav G. p53 dynamics vary between tissues and are linked with radiation sensitivity. Nat Commun. 2021 02 09; 12(1):898. PMID: 33563973; PMCID: PMC7873198.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  10. Arlauckas S, Oh N, Li R, Weissleder R, Miller MA. Macrophage imaging and subset analysis using single-cell RNA sequencing. Nanotheranostics. 2021; 5(1):36-56. PMID: 33391974.
    Citations: 3     Fields:    Translation:HumansCells
  11. Gerosa L, Chidley C, Fröhlich F, Sanchez G, Lim SK, Muhlich J, Chen JY, Vallabhaneni S, Baker GJ, Schapiro D, Atanasova MI, Chylek LA, Shi T, Yi L, Nicora CD, Claas A, Ng TSC, Kohler RH, Lauffenburger DA, Weissleder R, Miller MA, Qian WJ, Wiley HS, Sorger PK. Receptor-Driven ERK Pulses Reconfigure MAPK Signaling and Enable Persistence of Drug-Adapted BRAF-Mutant Melanoma Cells. Cell Syst. 2020 11 18; 11(5):478-494.e9. PMID: 33113355.
    Citations: 22     Fields:    Translation:HumansCells
  12. Ng TSC, Gunda V, Li R, Prytyskach M, Iwamoto Y, Kohler RH, Parangi S, Weissleder R, Miller MA. Detecting Immune Response to Therapies Targeting PDL1 and BRAF by Using Ferumoxytol MRI and Macrin in Anaplastic Thyroid Cancer. Radiology. 2021 01; 298(1):123-132. PMID: 33107799.
    Citations: 8     Fields:    Translation:AnimalsCells
  13. Luthria G, Li R, Wang S, Prytyskach M, Kohler RH, Lauffenburger DA, Mitchison TJ, Weissleder R, Miller MA. In vivo microscopy reveals macrophage polarization locally promotes coherent microtubule dynamics in migrating cancer cells. Nat Commun. 2020 07 14; 11(1):3521. PMID: 32665556.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  14. Wang SJ, Li R, Ng TSC, Luthria G, Oudin MJ, Prytyskach M, Kohler RH, Weissleder R, Lauffenburger DA, Miller MA. Efficient blockade of locally reciprocated tumor-macrophage signaling using a TAM-avid nanotherapy. Sci Adv. 2020 05; 6(21):eaaz8521. PMID: 32494745; PMCID: PMC7244320.
    Citations: 8     Fields:    
  15. Baskaran JP, Weldy A, Guarin J, Munoz G, Shpilker PH, Kotlik M, Subbiah N, Wishart A, Peng Y, Miller MA, Cowen L, Oudin MJ. Cell shape, and not 2D migration, predicts extracellular matrix-driven 3D cell invasion in breast cancer. APL Bioeng. 2020 Jun; 4(2):026105. PMID: 32455252; PMCID: PMC7202897.
    Citations: 10     
  16. Ng TSC, Garlin MA, Weissleder R, Miller MA. Improving nanotherapy delivery and action through image-guided systems pharmacology. Theranostics. 2020; 10(3):968-997. PMID: 31938046.
    Citations: 18     Fields:    Translation:HumansAnimals
  17. Gorry M, Yoneyama T, Vujanovic L, Moss ML, Garlin MA, Miller MA, Herman J, Stabile LP, Vujanovic NL. Development of flow cytometry assays for measuring cell-membrane enzyme activity on individual cells. J Cancer. 2020; 11(3):702-715. PMID: 31942194.
    Citations: 1     
  18. Ahrens CC, Chiswick EL, Ravindra KC, Miller MA, Ramseier JY, Isaacson KB, Lauffenburger DA, Griffith LG. Development and Application of the Metalloprotease Activity Multiplexed Bead-Based Immunoassay (MAMBI). Biochemistry. 2019 09 24; 58(38):3938-3942. PMID: 31474112.
    Citations: 1     Fields:    Translation:HumansCells
  19. Li R, Attari A, Prytyskach M, Garlin MA, Weissleder R, Miller MA. Single-Cell Intravital Microscopy of Trastuzumab Quantifies Heterogeneous in vivo Kinetics. Cytometry A. 2020 05; 97(5):528-539. PMID: 31423731.
    Citations: 7     Fields:    Translation:HumansCells
  20. Miller MA, Mikula H, Luthria G, Li R, Kronister S, Prytyskach M, Kohler RH, Mitchison T, Weissleder R. Modular Nanoparticulate Prodrug Design Enables Efficient Treatment of Solid Tumors Using Bioorthogonal Activation. ACS Nano. 2018 12 26; 12(12):12814-12826. PMID: 30550257.
    Citations: 21     Fields:    Translation:HumansAnimalsCells
  21. Kim HY, Li R, Ng TSC, Courties G, Rodell CB, Prytyskach M, Kohler RH, Pittet MJ, Nahrendorf M, Weissleder R, Miller MA. Quantitative Imaging of Tumor-Associated Macrophages and Their Response to Therapy Using 64Cu-Labeled Macrin. ACS Nano. 2018 12 26; 12(12):12015-12029. PMID: 30508377.
    Citations: 45     Fields:    Translation:AnimalsCells
  22. Pineda JJ, Miller MA, Song Y, Kuhn H, Mikula H, Tallapragada N, Weissleder R, Mitchison TJ. Site occupancy calibration of taxane pharmacology in live cells and tissues. Proc Natl Acad Sci U S A. 2018 11 27; 115(48):E11406-E11414. PMID: 30429313; PMCID: PMC6275538.
    Citations: 7     Fields:    Translation:HumansCells
  23. Ng EX, Sun G, Wei SC, Miller MA, DasGupta R, Lam PYP, Chen CH. Ultrafast Single-Cell Level Enzymatic Tumor Profiling. Anal Chem. 2019 01 15; 91(2):1277-1285. PMID: 30362713.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  24. Yoneyama T, Gorry M, Sobo-Vujanovic A, Lin Y, Vujanovic L, Gaither-Davis A, Moss ML, Miller MA, Griffith LG, Lauffenburger DA, Stabile LP, Herman J, Vujanovic NL. ADAM10 Sheddase Activity is a Potential Lung-Cancer Biomarker. J Cancer. 2018; 9(14):2559-2570. PMID: 30026855; PMCID: PMC6036891.
    Citations: 15     
  25. Miller MA, Kim E, Cuccarese MF, Plotkin AL, Prytyskach M, Kohler RH, Pittet MJ, Weissleder R. Near infrared imaging of Mer tyrosine kinase (MERTK) using MERi-SiR reveals tumor associated macrophage uptake in metastatic disease. Chem Commun (Camb). 2017 Dec 19; 54(1):42-45. PMID: 29185561; PMCID: PMC5736449.
    Citations: 8     Fields:    Translation:AnimalsCells
  26. Yoneyama T, Gorry M, Miller MA, Gaither-Davis A, Lin Y, Moss ML, Griffith LG, Lauffenburger DA, Stabile LP, Herman JG, Vujanovic NL. Modification of proteolytic activity matrix analysis (PrAMA) to measure ADAM10 and ADAM17 sheddase activities in cell and tissue lysates. J Cancer. 2017; 8(19):3916-3932. PMID: 29187866; PMCID: PMC5705993.
    Citations: 2     
  27. Conrad C, Dorzweiler K, Miller MA, Lauffenburger DA, Strik H, Bartsch JW. Profiling of metalloprotease activities in cerebrospinal fluids of patients with neoplastic meningitis. Fluids Barriers CNS. 2017 Aug 14; 14(1):22. PMID: 28806983.
    Citations: 8     Fields:    Translation:Humans
  28. Miller MA, Askevold B, Mikula H, Kohler RH, Pirovich D, Weissleder R. Nano-palladium is a cellular catalyst for in vivo chemistry. Nat Commun. 2017 07 12; 8:15906. PMID: 28699627.
    Citations: 53     Fields:    Translation:HumansAnimalsCells
  29. Miller MA, Arlauckas S, Weissleder R. Prediction of Anti-cancer Nanotherapy Efficacy by Imaging. Nanotheranostics. 2017; 1(3):296-312. PMID: 29071194.
    Citations: 30     Fields:    
  30. Miller MA, Weissleder R. Imaging of anticancer drug action in single cells. Nat Rev Cancer. 2017 06 23; 17(7):399-414. PMID: 28642603.
    Citations: 34     Fields:    Translation:HumansAnimals
  31. Miller MA. Driver mutations take the wheel in invasive yet nonmalignant disease. Sci Transl Med. 2017 06 07; 9(393). PMID: 28592567.
    Citations:    Fields:    Translation:Humans
  32. Miller MA, Chandra R, Cuccarese MF, Pfirschke C, Engblom C, Stapleton S, Adhikary U, Kohler RH, Mohan JF, Pittet MJ, Weissleder R. Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts. Sci Transl Med. 2017 05 31; 9(392). PMID: 28566423; PMCID: PMC6681815.
    Citations: 80     Fields:    Translation:HumansAnimalsCells
  33. Arlauckas SP, Garris CS, Kohler RH, Kitaoka M, Cuccarese MF, Yang KS, Miller MA, Carlson JC, Freeman GJ, Anthony RM, Weissleder R, Pittet MJ. In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy. Sci Transl Med. 2017 05 10; 9(389). PMID: 28490665; PMCID: PMC5734617.
    Citations: 241     Fields:    Translation:HumansAnimalsCells
  34. Miller MA. Nanoparticles improve economic mileage for CARs. Sci Transl Med. 2017 04 26; 9(387). PMID: 28446684.
    Citations: 2     Fields:    Translation:HumansCells
  35. Miller MA. Richer data with personalized GEMs. Sci Transl Med. 2017 03 15; 9(381). PMID: 28298424.
    Citations:    Fields:    Translation:Humans
  36. Cuccarese MF, Dubach JM, Pfirschke C, Engblom C, Garris C, Miller MA, Pittet MJ, Weissleder R. Heterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging. Nat Commun. 2017 02 08; 8:14293. PMID: 28176769.
    Citations: 72     Fields:    Translation:HumansAnimalsCells
  37. Conrad C, Miller MA, Bartsch JW, Schlomann U, Lauffenburger DA. Simultaneous Detection of Metalloprotease Activities in Complex Biological Samples Using the PrAMA (Proteolytic Activity Matrix Assay) Method. Methods Mol Biol. 2017; 1574:243-253. PMID: 28315256.
    Citations: 4     Fields:    Translation:HumansCells
  38. Miller MA, Sullivan RJ, Lauffenburger DA. Molecular Pathways: Receptor Ectodomain Shedding in Treatment, Resistance, and Monitoring of Cancer. Clin Cancer Res. 2017 Feb 01; 23(3):623-629. PMID: 27895032; PMCID: PMC5290119.
    Citations: 43     Fields:    Translation:HumansCells
  39. Oudin MJ, Barbier L, Schäfer C, Kosciuk T, Miller MA, Han S, Jonas O, Lauffenburger DA, Gertler FB. MENA Confers Resistance to Paclitaxel in Triple-Negative Breast Cancer. Mol Cancer Ther. 2017 01; 16(1):143-155. PMID: 27811011; PMCID: PMC5359014.
    Citations: 14     Fields:    Translation:HumansAnimalsCells
  40. Moss ML, Miller MA, Vujanovic N, Yoneyama T, Rasmussen FH. Fluorescent substrates for ADAM15 useful for assaying and high throughput screening. Anal Biochem. 2016 12 01; 514:42-47. PMID: 27637923.
    Citations: 2     Fields:    Translation:HumansCells
  41. Oudin MJ, Miller MA, Klazen JA, Kosciuk T, Lussiez A, Hughes SK, Tadros J, Bear JE, Lauffenburger DA, Gertler FB. MenaINV mediates synergistic cross-talk between signaling pathways driving chemotaxis and haptotaxis. Mol Biol Cell. 2016 10 15; 27(20):3085-3094. PMID: 27559126; PMCID: PMC5063616.
    Citations: 8     Fields:    Translation:AnimalsCells
  42. Miller MA, Weissleder R. Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior. Adv Drug Deliv Rev. 2017 04; 113:61-86. PMID: 27266447; PMCID: PMC5136524.
    Citations: 25     Fields:    Translation:Humans
  43. Miller MA, Oudin MJ, Sullivan RJ, Wang SJ, Meyer AS, Im H, Frederick DT, Tadros J, Griffith LG, Lee H, Weissleder R, Flaherty KT, Gertler FB, Lauffenburger DA. Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance. Cancer Discov. 2016 Apr; 6(4):382-99. PMID: 26984351.
    Citations: 88     Fields:    Translation:HumansAnimalsCells
  44. Ng EX, Miller MA, Jing T, Chen CH. Single cell multiplexed assay for proteolytic activity using droplet microfluidics. Biosens Bioelectron. 2016 Jul 15; 81:408-414. PMID: 26995287.
    Citations: 18     Fields:    Translation:HumansCells
  45. Miller MA, Gadde S, Pfirschke C, Engblom C, Sprachman MM, Kohler RH, Yang KS, Laughney AM, Wojtkiewicz G, Kamaly N, Bhonagiri S, Pittet MJ, Farokhzad OC, Weissleder R. Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle. Sci Transl Med. 2015 Nov 18; 7(314):314ra183. PMID: 26582898.
    Citations: 116     Fields:    Translation:HumansAnimalsCells
  46. Miller MA, Zheng YR, Gadde S, Pfirschke C, Zope H, Engblom C, Kohler RH, Iwamoto Y, Yang KS, Askevold B, Kolishetti N, Pittet M, Lippard SJ, Farokhzad OC, Weissleder R. Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug. Nat Commun. 2015 Oct 27; 6:8692. PMID: 26503691; PMCID: PMC4711745.
    Citations: 142     Fields:    Translation:HumansAnimalsCells
  47. Miller MA, Moss ML, Powell G, Petrovich R, Edwards L, Meyer AS, Griffith LG, Lauffenburger DA. Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain. Sci Rep. 2015 Oct 19; 5:15150. PMID: 26477568.
    Citations: 16     Fields:    Translation:HumansCells
  48. Vinegoni C, Dubach JM, Thurber GM, Miller MA, Mazitschek R, Weissleder R. Advances in measuring single-cell pharmacology in vivo. Drug Discov Today. 2015 Sep; 20(9):1087-92. PMID: 26024776; PMCID: PMC4567932.
    Citations: 13     Fields:    Translation:HumansAnimals
  49. Ng EX, Miller MA, Jing T, Lauffenburger DA, Chen CH. Low-volume multiplexed proteolytic activity assay and inhibitor analysis through a pico-injector array. Lab Chip. 2015 Feb 21; 15(4):1153-9. PMID: 25553996.
    Citations: 5     Fields:    Translation:HumansCells
  50. Schlomann U, Koller G, Conrad C, Ferdous T, Golfi P, Garcia AM, Höfling S, Parsons M, Costa P, Soper R, Bossard M, Hagemann T, Roshani R, Sewald N, Ketchem RR, Moss ML, Rasmussen FH, Miller MA, Lauffenburger DA, Tuveson DA, Nimsky C, Bartsch JW. ADAM8 as a drug target in pancreatic cancer. Nat Commun. 2015 Jan 28; 6:6175. PMID: 25629724; PMCID: PMC5014123.
    Citations: 40     Fields:    Translation:HumansAnimalsCells
  51. Laughney AM, Kim E, Sprachman MM, Miller MA, Kohler RH, Yang KS, Orth JD, Mitchison TJ, Weissleder R. Single-cell pharmacokinetic imaging reveals a therapeutic strategy to overcome drug resistance to the microtubule inhibitor eribulin. Sci Transl Med. 2014 Nov 05; 6(261):261ra152. PMID: 25378644.
    Citations: 34     Fields:    Translation:HumansAnimalsCells
  52. Turetsky A, Kim E, Kohler RH, Miller MA, Weissleder R. Single cell imaging of Bruton's tyrosine kinase using an irreversible inhibitor. Sci Rep. 2014 Apr 24; 4:4782. PMID: 24759210; PMCID: PMC3998017.
    Citations: 14     Fields:    Translation:HumansAnimalsCells
  53. Miller MA, Askevold B, Yang KS, Kohler RH, Weissleder R. Platinum compounds for high-resolution in vivo cancer imaging. ChemMedChem. 2014 Jun; 9(6):1131-5. PMID: 24504646.
    Citations: 26     Fields:    Translation:HumansAnimalsCells
  54. Meyer AS, Miller MA, Gertler FB, Lauffenburger DA. The receptor AXL diversifies EGFR signaling and limits the response to EGFR-targeted inhibitors in triple-negative breast cancer cells. Sci Signal. 2013 Aug 06; 6(287):ra66. PMID: 23921085.
    Citations: 142     Fields:    Translation:HumansCells
  55. Dang M, Armbruster N, Miller MA, Cermeno E, Hartmann M, Bell GW, Root DE, Lauffenburger DA, Lodish HF, Herrlich A. Regulated ADAM17-dependent EGF family ligand release by substrate-selecting signaling pathways. Proc Natl Acad Sci U S A. 2013 Jun 11; 110(24):9776-81. PMID: 23720309.
    Citations: 40     Fields:    Translation:HumansCells
  56. Miller MA, Meyer AS, Beste MT, Lasisi Z, Reddy S, Jeng KW, Chen CH, Han J, Isaacson K, Griffith LG, Lauffenburger DA. ADAM-10 and -17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling. Proc Natl Acad Sci U S A. 2013 May 28; 110(22):E2074-83. PMID: 23674691.
    Citations: 38     Fields:    Translation:HumansCells
  57. Chen CH, Miller MA, Sarkar A, Beste MT, Isaacson KB, Lauffenburger DA, Griffith LG, Han J. Multiplexed protease activity assay for low-volume clinical samples using droplet-based microfluidics and its application to endometriosis. J Am Chem Soc. 2013 Feb 06; 135(5):1645-8. PMID: 23157326.
    Citations: 28     Fields:    Translation:HumansCells
  58. Miller MA, Feng XJ, Li G, Rabitz HA. Identifying biological network structure, predicting network behavior, and classifying network state with High Dimensional Model Representation (HDMR). PLoS One. 2012; 7(6):e37664. PMID: 22723838.
    Citations: 7     Fields:    Translation:Cells
  59. Moss ML, Powell G, Miller MA, Edwards L, Qi B, Sang QX, De Strooper B, Tesseur I, Lichtenthaler SF, Taverna M, Zhong JL, Dingwall C, Ferdous T, Schlomann U, Zhou P, Griffith LG, Lauffenburger DA, Petrovich R, Bartsch JW. ADAM9 inhibition increases membrane activity of ADAM10 and controls a-secretase processing of amyloid precursor protein. J Biol Chem. 2011 Nov 25; 286(47):40443-51. PMID: 21956108.
    Citations: 29     Fields:    Translation:HumansCells
  60. Chen CH, Sarkar A, Song YA, Miller MA, Kim SJ, Griffith LG, Lauffenburger DA, Han J. Enhancing protease activity assay in droplet-based microfluidics using a biomolecule concentrator. J Am Chem Soc. 2011 Jul 13; 133(27):10368-71. PMID: 21671557.
    Citations: 18     Fields:    Translation:AnimalsCells
  61. Miller MA, Barkal L, Jeng K, Herrlich A, Moss M, Griffith LG, Lauffenburger DA. Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous determination of multiple protease activities. Integr Biol (Camb). 2011 Apr; 3(4):422-38. PMID: 21180771.
    Citations: 43     Fields:    Translation:HumansAnimalsCells
  62. Miller M, Feng X, Li G, Rabitz H. Nonlinear bionetwork structure inference using the random sampling-high dimensional model representation (RS-HDMR) algorithm. Annu Int Conf IEEE Eng Med Biol Soc. 2009; 2009:6412-5. PMID: 19964421.
    Citations:    Fields:    Translation:Cells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Miller's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (297)
Co-Authors (63)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.